Impax to ramp up spending after US FDA gives California plant the all clear
Impax Laboratories has received the all clear from the US FDA regarding its manufacturing plant in California hit with a Warning Letter in 2011.
Archives for September 7, 2015
Novo Nordisk and MIT on the hunt for oral peptide route
Novo Nordisk is collaborating with MIT on new ways to deliver peptides.
Bilcare buys Singapore plant and expands German site
Contract packaging firm Bilcare Research AG has announced an expansion plan for its manufacturing site in Bötzingen, Germany.
Recipharm wins 3-year Parkinson’s drug contract
CDMO Recipharm has signed a deal to manufacture a Parkinson’s therapy for Swedish pharma company LobSor.
Cipla and Lannett add US plants as generics industry continues to consolidate
Cipla and Lannett have expanded their presence in the mid-sized US generics space through acquisitions totalling over $1.5bn.
Sanofi blames manufacturing costs for end of snake bite cure
Sanofi’s decision to stop manufacturing an anti-venom will contribute to “needless death and disability” for snake bite victims, according to Médecins Sans Frontières.